Skip to content

Interest of TTC for the Early Diagnosis of Acute Myocardial Infarction at Autopsy

Interest of Triphenyl Tetrazolium Chloride (TTC) for the Early Diagnosis of Acute Myocardial Infarction at Autopsy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04924426
Acronym
INFARCTOPSY
Enrollment
40
Registered
2021-06-14
Start date
2021-05-01
Completion date
2022-08-30
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Early Acute Myocardial Infarction, TTC, Sudden death, Early markers, biochemicla markers

Brief summary

Ischemic heart disease is the leading cause of death worldwide and the leading cause of sudden cardiac death. However, its post-mortem diagnosis is particularly difficult because the gross examination of the heart is usually normal at the autopsy . The diagnosis is therefore often based on a set of indirect arguments, such as the patient's medical and clinical history and the degree of occlusion of the coronary arteries. The formal diagnosis of acute myocardial infarction (AMI) currently relies on standard histological examination. However, histological findings often require a prolonged survival time of several hours to be highlighted. Triphenyltetrazolium chloride (TTC) is a salt that reacts with lactate dehydrogenases contained in still viable myocardial cells, forming a red pigment visible to the naked eye, (1,3,5 triphenylformazan). Ischemia-induced cell death, which occurs within minutes of the causative event, is responsible for the leakage of lactate deshydrogenase into the extracellular medium and thus results in the absence of formazan formation in the infarcted area, which displays an easily identifiable pale unstained color. It has been suggested that the use of TTC would allow the identification of MI as early as one hour of survival in animal models, before the usual macroscopic and microscopic signs are visible. It could therefore represent an attractive forensic tool for the early diagnosis of AMI at the autopsy.

Interventions

PROCEDURETTC immersion

TTC immersion

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients autopsied at the Forensic Institute of the CHU of MONTPELLIER whose ante-mortem (medical history, cardiovascular risk factors, clinical history) and autopsy data (significant coronary stenosis associated or not with an endoluminal thrombus, scars of old infarction, absence of other identified cause of death) suggest AMI as the cause of death. * Known survival time and postmortem interval.

Exclusion criteria

\- Putrefied bodies

Design outcomes

Primary

MeasureTime frameDescription
Negative colorimetric reaction to TTC of infarcted myocardial tissueday 1Negative colorimetric reaction to TTC of infarcted myocardial tissue

Secondary

MeasureTime frameDescription
Survival time (time from initial symptoms to death)day 1Survival time (time from initial symptoms to death)
Post-mortem interval (time from death to autopsy)day 1Post-mortem interval (time from death to autopsy)

Countries

France

Contacts

Primary ContactManon Blanc, resident
ma-blanc@chu-montpellier.fr06-15-63-14-58

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026